Interventional Oncology Devices – Market Insights – United States
The US market for interventional oncology devices will grow through 2032. This will be driven largely by the increasing shift toward higher-priced technologies, such as radioembolization, and expanding populations that are treatable with ablation.
This Medtech 360 Report provides comprehensive data and analysis on the state of the market for interventional oncology devices in the US from 2019 through 2032.
The COVID-19 pandemic had short term consequences on the interventional oncology device market.
To what extent did COVID-19 affect the different procedure types in the interventional oncology device market?
How has recovery progressed in this space?
The adoption rates of different ablation modalities have shifted in recent years.
How will growth vary across different ablation device categories?
How strongly are cryoablation and IRE ablation being adopted?
What are the key ongoing clinical trials related to ablation, and what implications might they have on the interventional oncology device market?
Newer embolization technologies are seeing increasing adoption.
What is the adoption outlook for different embolization devices, and what factors will affect the uptake of these technologies over the forecast period?
What impact will clinical guidance have on the adoption of newer technologies in the embolization device market?
How will the adoption of radioembolization spheres be affected by recent clinical trials?
Table of contents
- Interventional Oncology Devices - Market Insights - United States
- Abstract
- Executive Summary
- COVID-19 Updates
- Market Highlights
- Interventional Oncology Device Market, by Product Type, US (USD), 2019u20132032
- Interventional Oncology Device Market Landscape, US (USD), 2022 and 2032
- Competitive Highlights
- Interventional Oncology Device Revenue Market Share Rankings, by Product Type, US, 2022
- Competitive Insights
- Companies Mentioned
- Market Developments
- Recent Events in the Interventional Oncology Device Market, US
- Key Clinical Trials in the Interventional Oncology Device Market, US
- Emerging Products for the Interventional Oncology Device Market, US
- Procedures Covered
- Interventional Oncology Procedures Covered, US
- Products Covered
- Interventional Oncology Products Covered, US
- COVID-19 Updates
- Key Report Updates
- Interventional Oncology Device Market
- Market Highlights
- Key Content Updates
- US Interventional Oncology Device Market Drivers
- US Interventional Oncology Device Market Limiters
- Interventional Oncology Device Market, by Product Type, US (USD), 2019u20132032
- Market Definitions
- Market Forecast Data
- Interventional Oncology Procedures, by Procedure Type, US, 2019u20132032
- Interventional Oncology Procedures, by Indication, US, 2019u20132032
- Interventional Oncology Device Market, by Product Type, US (USD), 2019u20132032
- Interventional Oncology Device Market Growth, by Product Type, US, 2020u20132032
- Market Shares
- Interventional Oncology Device Revenue Market Shares, US, 2022
- Interventional Oncology Device Revenue Market Shares, by Product Type, US, 2022
- Competitive Insights
- Boston Scientific Competitive Insights
- Sirtex Medical Competitive Insights
- Competitive Insights for Other Key Competitors
- Market Developments
- Recent Events in the Interventional Oncology Device Market, US
- Key Clinical Trials in the Interventional Oncology Device Market, US
- Emerging Products for the Interventional Oncology Device Market, US
- Market Highlights
- Ablation Device Market
- Market Highlights
- Key Content Updates
- US Ablation Device Market Drivers
- US Ablation Device Market Limiters
- Ablation Device Market, by Product Type, US (USD), 2019u20132032
- Market Definitions
- Market Forecast Data
- Ablation Procedures, by Indication, US, 2019u20132032
- Ablation Procedures, by Product Type, US, 2019u20132032
- Primary Liver Cancer Ablation Procedures, by Procedure Type, US, 2019u20132032
- Secondary Liver Cancer Ablation Procedures, by Procedure Type, US, 2019u20132032
- Kidney Cancer Ablation Procedures, by Procedure Type, US, 2019u20132032
- Lung Cancer Ablation Procedures, by Procedure Type, US, 2019u20132032
- Bone Cancer Ablation Procedures, by Procedure Type, US, 2019u20132032
- Pancreatic & Pelvic Cancer Ablation Procedures, by Procedure Type, US, 2019u20132032
- Ablation Disposables Market, by Product Type, US (USD), 2019u20132032
- Ablation Disposables Market Growth, by Product Type, US, 2020u20132032
- Ablation Capital Equipment Market, by Product Type, US (USD), 2019u20132032
- Ablation Capital Equipment Market Growth, by Product Type, US, 2020u20132032
- RF Ablation Procedures, by Indication, US, 2019u20132032
- RF Ablation Device Market, by Component, US (USD), 2019u20132032
- RF Ablation Device Market Growth, by Component, US, 2020u20132032
- Microwave Ablation Procedures, by Indication, US, 2019u20132032
- Microwave Ablation Device Market, by Component, US (USD), 2019u20132032
- Microwave Ablation Device Market Growth, by Component, US, 2020u20132032
- Cryoablation Procedures, by Indication, US, 2019u20132032
- Cryoablation Device Market, US (USD), 2019u20132032
- Cryoablation Device Market Growth, US, 2020u20132032
- IRE Ablation Procedures, by Indication, US, 2019u20132032
- IRE Ablation Device Market, US (USD), 2019u20132032
- IRE Ablation Device Market Growth, by Component, US, 2020u20132032
- Market Shares
- Ablation Device Revenue Market Shares, US, 2022
- Ablation Device Revenue Market Shares, by Product Type, US, 2022
- Competitive Insights
- Market Highlights
- Embolization Particle Market
- Market Highlights
- Key Content Updates
- US Embolization Particle Market Drivers
- US Embolization Particle Market Limiters
- Embolization Particle Market, by Product Type, US (USD), 2019u20132032
- Market Definitions
- Market Forecast Data
- Embolization Particle Procedures, by Indication, US, 2019u20132032
- Embolization Particle Procedures, by Product Type, US, 2019u20132032
- Primary Liver Cancer Embolization Particle Procedures, by Procedures Type, US, 2019u20132032
- Secondary Liver Cancer Embolization Particle Procedures, by Procedures Type, US, 2019u20132032
- Kidney Cancer Embolization Particle Procedures, US, 2019u20132032
- Embolization Particle Market, by Product Type, US (USD), 2019u20132032
- Embolization Particle Market Growth, by Product Type, US, 2020u20132032
- PVA Particle Procedures, by Indication, US, 2019u20132032
- PVA Particle Market, US (USD), 2019u20132032
- Microsphere Procedures, by Indication, US, 2019u20132032
- Microsphere Market, US (USD), 2019u20132032
- DEB Procedures, by Indication, US, 2019u20132032
- DEB Market, US (USD), 2019u20132032
- Radioembolization Procedures, by Indication, US, 2019u20132032
- Radioembolization Sphere Market, US (USD), 2019u20132032
- Market Shares
- Embolization Particle Revenue Market Shares, US, 2022
- Embolization Particle Revenue Market Shares, by Product Type, US, 2022
- Competitive Insights
- Market Highlights
- Accessory Device Market
- Market Highlights
- Key Content Updates
- US Accessory Device Market Drivers
- US Accessory Device Market Limiters
- Accessory Device Market, by Product Type, US (USD), 2019u20132032
- Market Definitions
- Market Forecast Data
- Accessory Device Market, by Product Type, US (USD), 2019u20132032
- Accessory Device Market Growth, by Product Type, US, 2020u20132032
- Market Shares
- Accessory Device Revenue Market Shares, US, 2022
- Accessory Devices Revenue Market Shares, by Product Type, US, 2022
- Competitive Insights
- Market Highlights
- Appendix
- Abbreviations
- Bibliography
- Abbreviations
Raihan Jiwa is an analyst on the Cardiovascular Medtech Insights team at Clarivate. Raihan graduated from Western University with an Honors Specialization in Synthetic Biology. Raihan’s interest lies in the MedTech space as well as in the future of genetic engineering and development of healthcare systems in developing economies.